One is to conjugating a targeting molecule, transferrin (Tf), which has been reported to be targeted to NPC cells (Liu et al., 2018); the other is to use a chemotherapy self-sensibilized delivery system, which could enhance the chemotherapy effect of the prodrug. The gene discussed is TF; the disease is nasopharyngeal carcinoma.